PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypercalcemia |
| Phenotype | C0020503|secondary hyperparathyroidism |
| Sentences | 2 |
| PubMedID- 24959180 | Cinacalcet (sensipar), a calcimimetic drug, is available for the treatment of secondary hyperparathyroidism associated with renal failure, hypercalcemia in parathyroid cancer, and the treatment of severe hypercalcemia in patients with primary hyperparathyroidism unable to undergo parathyroidectomy [17–19]. |
| PubMedID- 22577545 | In addition to the previous mechanism, several other factors like uremic toxins, increased circulating endogenous nos inhibitors like asymmetric dimethylarginine, secondary hyperparathyroidism leading to hypercalcemia, and increased expression of endothelin a receptors have also been implicated in the pathogenesis of hypertension in ckd. |
Page: 1